LeMaitre Vascular Stock Price and Value Analysis

Should you buy LeMaitre Vascular stock? (NasdaqGM:LMAT). Let's see how it does in our automated value investing analysis system.

Key Facts

  • Ticker: LMAT (NasdaqGM)
  • Sector: Unknown
  • Industry: Unknown
  • Dividend yield:

Advertisement helps keep Trendshare free for most readers.

Hold-time calculator

Estimate how long you need to hold LeMaitre Vascular to reach your target.

Target type
AdvantagesDisadvantages
None.
  • This company has wild ups and downs.
  • This company is making money at a modest rate.
  • This company is less known than others.
  • This stock looks overpriced.
  • This company has a low dividend yield.

Inside the LMAT Numbers

LMAT Price
(LeMaitre Vascular stock price per share)
$84.96
[?] LMAT Fair Price
(based on intrinsic value)
$7.28
[?] LMAT Safety Price (based on a variable margin of safety) $4.37
[?] PE Ratio versus Sector 94% higher than other Unknown stocks
[?] PE Ratio versus Industry 63% higher than other Unknown stocks
[?] Free Cash Flow Jitter 59%
[?] Dividend Yield 1% (tax impact)
Shares Shorted 1,084,587

This stock has short interest! This means that people have shorted it.

Why does that matter? They've made a bet that price will decrease from where they bought it. Maybe there are financial problems, or maybe there's a value play.

As of the latest analysis, there are 1,084,587 shares shorted. With 20,852,739 shares available for purchase and an average trading volume over the past 10 trading days of 212,050, it would take at least 5.115 days for all of the short holders to cover their shorts.

Continue Learning: Value Investing Guides

Is LeMaitre Vascular Stock on Sale?

We believe that LeMaitre Vascular may be worth examining further. It's making money, which is a very positive sign. Is it on sale?

LeMaitre Vascular looks overpriced right now. If you're looking for a bargain in the stock market, you should probably look elsewhere for a great deal. This might still be a great stock to own—but it's not on sale right now.

Advertisement supports free stock analysis content.

Should You Buy LMAT Stock?

Does LeMaitre Vascular have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.

Worked example: LMAT

This example shows how we apply the Trendshare checklist to LMAT: earnings power, cash generation, valuation, and margin of safety.

We check: business quality, free cash flow, P/E, and margin of safety.

  1. Step 1 — Snapshot

    • Price: 84.96
    • Market cap: $1.9B
    • EPS: 2.32
  2. Step 2 — Valuation checks

    • P/E: 36.621
    • FCF yield:
    • Date checked: Dec 26, 2025
  3. Step 3 — Margin of safety

    • Compare price to fair value and safety price.
    • Look for durable cash generation and reasonable leverage.
    • Decide if it passes your personal checklist.
Illustrative sparkline of recent price-like movements (not an actual price series). The blue line shows a simplified trend; the gray baseline is a notional recent level. This graphic is a visual aid only — use the numeric values in the steps above for decisions.